Wells Fargo & Company Ampio Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $201 - $52,815	-2,515 Reduced 64.26%	1,399 $0
Q2 2022 Aug 12, 2022	SELL	$0.16 - $0.47 $7,300 - $21,445	-45,629 Reduced 92.1%	3,914 $0
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $28,462 - $42,016	-67,769 Reduced 57.77%	49,543 $24,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $61,774 - $188,633	110,312 Added 1575.89%	117,312 $67,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $1,662 - $2,473	-1,374 Reduced 16.41%	7,000 $12,000
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $11,180 - $14,190	-7,167 Reduced 46.12%	8,374 $14,000
Q1 2021 May 13, 2021	SELL	$1.36 - $2.49 $203,465 - $372,521	-149,607 Reduced 90.59%	15,541 $26,000
Q4 2020 Feb 09, 2021	SELL	$0.75 - $2.76 $74,769 - $275,149	-99,692 Reduced 37.64%	165,148 $263,000
Q3 2020 Nov 05, 2020	BUY	$0.61 - $1.17 $42,197 - $80,937	69,177 Added 35.36%	264,840 $254,000
Q2 2020 Aug 13, 2020	BUY	$0.47 - $0.72 $83,187 - $127,435	176,994 Added 948.06%	195,663 $124,000
Q1 2020 May 14, 2020	BUY	$0.36 - $0.74 $6,720 - $13,815	18,669 New	18,669 $7,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.